Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Differential in vivo biodistribution of 131I-labeled exosomes from diverse cellular origins and its implication for theranostic application.

Rashid MH, Borin TF, Ara R, Angara K, Cai J, Achyut BR, Liu Y, Arbab AS.

Nanomedicine. 2019 Aug 1;21:102072. doi: 10.1016/j.nano.2019.102072. [Epub ahead of print]

2.

Corrigendum to "CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma" Neoplasia, October 2018, Volume 20, Issue 10, Pages 1070-1082.

Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS.

Neoplasia. 2019 Jan;21(1):156-157. doi: 10.1016/j.neo.2018.11.001. No abstract available.

3.

CXCR2-Expressing Tumor Cells Drive Vascular Mimicry in Antiangiogenic Therapy-Resistant Glioblastoma.

Angara K, Borin TF, Rashid MH, Lebedyeva I, Ara R, Lin PC, Iskander A, Bollag RJ, Achyut BR, Arbab AS.

Neoplasia. 2018 Oct;20(10):1070-1082. doi: 10.1016/j.neo.2018.08.011. Erratum in: Neoplasia. 2019 Jan;21(1):156-157.

4.

Arachidonic Acid Metabolite as a Novel Therapeutic Target in Breast Cancer Metastasis.

Borin TF, Angara K, Rashid MH, Achyut BR, Arbab AS.

Int J Mol Sci. 2017 Dec 8;18(12). pii: E2661. doi: 10.3390/ijms18122661. Review.

5.

Major Challenges and Potential Microenvironment-Targeted Therapies in Glioblastoma.

Arbab AS, Rashid MH, Angara K, Borin TF, Lin PC, Jain M, Achyut BR.

Int J Mol Sci. 2017 Dec 16;18(12). pii: E2732. doi: 10.3390/ijms18122732. Review.

6.

Canonical NFκB signaling in myeloid cells is required for the glioblastoma growth.

Achyut BR, Angara K, Jain M, Borin TF, Rashid MH, Iskander ASM, Ara R, Kolhe R, Howard S, Venugopal N, Rodriguez PC, Bradford JW, Arbab AS.

Sci Rep. 2017 Oct 23;7(1):13754. doi: 10.1038/s41598-017-14079-4.

7.

Malignant pericytes expressing GT198 give rise to tumor cells through angiogenesis.

Zhang L, Wang Y, Rashid MH, Liu M, Angara K, Mivechi NF, Maihle NJ, Arbab AS, Ko L.

Oncotarget. 2017 May 25;8(31):51591-51607. doi: 10.18632/oncotarget.18196. eCollection 2017 Aug 1.

8.

Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma.

Angara K, Borin TF, Arbab AS.

Transl Oncol. 2017 Aug;10(4):650-660. doi: 10.1016/j.tranon.2017.04.007. Epub 2017 Jun 29. Review.

9.

HET0016 decreases lung metastasis from breast cancer in immune-competent mouse model.

Borin TF, Shankar A, Angara K, Rashid MH, Jain M, Iskander A, Ara R, Lebedyeva I, Korkaya H, Achyut BR, Arbab AS.

PLoS One. 2017 Jun 13;12(6):e0178830. doi: 10.1371/journal.pone.0178830. eCollection 2017.

10.

Anti-VEGFR2 driven nuclear translocation of VEGFR2 and acquired malignant hallmarks are mutation dependent in glioblastoma.

Shankar A, Jain M, Lim MJ, Angara K, Zeng P, Arbab SA, Iskander A, Ara R, Arbab AS, Achyut BR.

J Cancer Sci Ther. 2016;8(7):172-178. doi: 10.4172/1948-5956.1000410. Epub 2016 Jul 15.

11.

Intravenous Formulation of HET0016 Decreased Human Glioblastoma Growth and Implicated Survival Benefit in Rat Xenograft Models.

Jain M, Gamage NH, Alsulami M, Shankar A, Achyut BR, Angara K, Rashid MH, Iskander A, Borin TF, Wenbo Z, Ara R, Ali MM, Lebedyeva I, Chwang WB, Guo A, Bagher-Ebadian H, Arbab AS.

Sci Rep. 2017 Jan 31;7:41809. doi: 10.1038/srep41809.

12.

Vascular mimicry in glioblastoma following anti-angiogenic and anti-20-HETE therapies.

Angara K, Rashid MH, Shankar A, Ara R, Iskander A, Borin TF, Jain M, Achyut BR, Arbab AS.

Histol Histopathol. 2017 Sep;32(9):917-928. doi: 10.14670/HH-11-856. Epub 2016 Dec 19.

13.

Targeting Bone Marrow to Potentiate the Anti-Tumor Effect of Tyrosine Kinase Inhibitor in Preclinical Rat Model of Human Glioblastoma.

Shaaban S, Alsulami M, Arbab SA, Ara R, Shankar A, Iskander A, Angara K, Jain M, Bagher-Ebadian H, Achyut BR, Arbab AS.

Int J Cancer Res. 2016;12(2):69-81. Epub 2016 Mar 15.

14.

Bone marrow derived myeloid cells orchestrate antiangiogenic resistance in glioblastoma through coordinated molecular networks.

Achyut BR, Shankar A, Iskander AS, Ara R, Angara K, Zeng P, Knight RA, Scicli AG, Arbab AS.

Cancer Lett. 2015 Dec 28;369(2):416-26. doi: 10.1016/j.canlet.2015.09.004. Epub 2015 Sep 21.

Supplemental Content

Loading ...
Support Center